You Position: Home > Paper
Myocardial infarction in a patient with systemic lupus erythematosus and antiphospholipid syndrome
( views:170, downloads:24 )
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 15
- DOI:
- 10.3760/cma.j.issn.0366-6999.2011.15.026
- Key Word:
- lupus erythematosus,systemic;antiphospholipid syndrome;acute myocardial infarction;risk factors;antiplatelet;warfarin
Abstract： This case report we presented aims to report a-31-year-old man with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) who developed myocardial infarction (Ml) and also aims to discuss the possible mechanisms. The results showed that traditional risk factors alone do not cause coronary heart disease with SLE, and SLE-related factors influence the atherogenic process. We found that although SLE patients with acute Ml benefit from percutaneous coronary intervention (PCI) therapy, it is very important to choose the reasonable antithrombotic strategies in patients with SLE and APS undergoing PCI who require oral anticoagulant therapy.
- [1]C, Korkmaz,D U, Cansu,T, Ka?ifo?lu.Myocardial infarction in young patients (<or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature.[J].2007,16(4).
- [2]M C, Hochberg.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.[J].1997,40(9).
- [3]Levine S. R.,Salowich-Palm L.,Sawaya K. L.,etc.IgG Anticardiolipin Antibody Titer>40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death: A Prospective Cohort Study[J].1997.
- [4]Khurram Z,Wong SC,Hong MK,etc.Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.[J].2006,18(4).
- [5]K, Takayanagi,Y, Nakamura,M, Kishimoto,etc.Cardiac rupture following acute myocardial infarction in systemic lupus erythematosus: case report.[J].1990,41.
- [6]Ramsey Goldman R,Rhew EY.Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.[J].2006,5(2).
- [7]N E, Doherty,R J, Siegel.Cardiovascular manifestations of systemic lupus erythematosus.[J].1985,110(6).
- [8]DeEugenio D,McGowan C,DeCaro M,etc.Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.[J].2007,27(5).
- [9]Shanker BA,Roman MJ,Lockshin MD,etc.Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.[J].2003,349(25).
- [10]Petri M.The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort.[J].2004,114(5).
- [11]Krilis SA,Koike T,Tincani A,etc.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).[J].2006,4(2).